New Vaccine Promises Defense Against Deadly Fungal Infections

Researchers at the University of Georgia are developing a vaccine called NXT-2 that shows promise in preventing and reducing the severity of fungal infections like Candida albicans, which causes yeast infections. The vaccine has demonstrated effectiveness in mice by generating a strong immune response and reducing fungal levels and inflammation, with plans to test it in women with recurrent yeast infections. This could lead to a broader, more effective treatment option for fungal infections that are increasingly resistant to current therapies.